http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
성인에 있어서의 혈장제 백신의 면역 지속성과 면역 증강 반응
선희식(H . S . Sun),정규원(K . W . Chung),김부성(B . S . Kim),노재철(J . C . Rho),정환국(W . K . Chung) 대한내과학회 1987 대한내과학회지 Vol.32 No.6
N/A To find out the persistence of the anti-HBs level in adult recipients after primary immunization with a vaccine and secondary boosting responses with another vaccine, we screened subjects who had no HBsAg, anti-HBs and anti-HBc before immunization with radioimmunoassay technique, and submitted them to primary immunization with a plasma-derived vaccine and secondary boosting with another plasma derivative. Finally, we could select 36 subjects who were possible to complete the follow-up study until after secondary boosting. The primary booster injection was performed at 6 months and secondary boosting at the 25th month after initial vaccination. Among 11 recipients, in whom antibody levels were increased by, more than 9,9 R.U. after primary boosting with 3 μg dose of vaccine prepared by A. Co. (V.A.) (well responders), anti-HBs levels decreased in all recipients at the 25th month after first vaccine treatment, and 4 of these showed negative seroconversion. In another 11 recipients, who had no antihody responses after inadequate primary vaccine treatment with V.A. (non-responders), no anti-HBs was found in their blood 25 months after vaccine initiation. At one month after secondary booster injection with 20 pg dose of hepatitis B vaccine provided by B. Co. (V. B.), a marked rise of anti-HBs titer was observed in all 11 well responders, and 6 of the 11 non-responders also responded. Among participants in this study, 14 who responded to primary immunization with V.B. but in whom no primary boosting effect was seen, 3 showed sero-negative conversion 25 months after vaccine initiation. A rise of more than 9.9R.U. of anti-HBs, after the secondary booster injection with V.A., was observed in 6 of the 14 subjects even in sero-negative cases.
포스터 전시 : 담도,췌장 ; 신경섬유종증을 동반한 췌장암 1예
김영환 ( Y. H. Kim ),이태규 ( T. K. Lee ),김성수 ( S. S. Kim ),방춘상 ( C. S. Bang ),채현석 ( H. S. Chae ),한석원 ( S. W. Han ),이창돈 ( C. D. Lee ),최규용 ( K. Y. Choi ),정인식 ( I. S. Chung ),선희식 ( H. S. Sun ),박도호 대한소화기학회 2002 대한소화기학회 춘계학술대회 Vol.2002 No.-
<증례> 54세 남자 환자가 전신쇄약감과 현기증을 주소로 내원하였다. 과거력상 심방세동 있었으며 가족력상 특이 사항 없었다. 이학적 소견상 만성병색 소견을 보이고 결막이 창백해보였으며 두경부 검사와 흉부 청진상 특이 소견 없었다. 복부 촉진상 상복부의 경미한 압통이 있었고 복부와 등, 얼굴 피부에도 밀크 커피색 반점을 동반한 다양한 크기의 종괴들이 관찰되었다. 검사실 소견에서 Hemoglobin 7.5g/dl, Hematocrit 24.0% 백혈구수 9
구연 / 제 4 회의장 / 간 12 : 원발성 간세포암에서 분화도에 따른 E - cadherin 과 β - catenin 발현양상 연구
배시현(S . H . Bae),정은선(E . S . Chung),박영민(Y . M . Park),박태욱(T . W . Park),변병훈(B . H . Byun),윤승규(S . K . Yoon),차상복(S . B . Cha),정규원(K . Y . Chung),선희식(H . S . Sun),박두호(D . H . Park),김부성(B . S . Kim) 대한소화기학회 1999 대한소화기학회 추계학술대회 Vol.1999 No.-
구연 / 제 4 회의장 / 간 4 : 비대상성 B 형 간경변증 환자들에 대한 장기간 Iamivudine 치료효과
박태옥(T . W . Park),박영민(Y . M . Park),배시현(S . H . Bae),변병훈(B . H . Byun),윤승규(S . K . Yoon),안병민(B . M . An),한준열(J . Y . Han),이창돈(C . D . Lee),차상복(S . B . Cha),정규원(K . Y . Chung),선희식(H . S . Sun),박두호(D . 대한소화기학회 1999 대한소화기학회 추계학술대회 Vol.1999 No.-
한국인 수혈후 간염과 만성 간질환 환자에서의 C형 간염바이러스 감염동태 (제1보)
정규원 ( Jeong Gyu Won ),선희식 ( Seon Hui Sig ),정환국 ( Jeong Hwan Gug ),신호균 ( Sin Ho Gyun ),박충기 ( Park Chung Gi ),유재영 ( Yu Jae Yeong ),( Adrian M. Di Bisceglie ),( Jeanne J. Waggoner ),( Jay H. Hoofnagle ) 대한내과학회 1990 대한내과학회지 Vol.38 No.6
N/A To investigate the prevalence of antibodies to hepatitis C virus infection in patients with various chronic liver diseases in Korea, we tested 240 serum samples using the Abbott enzyme immunoassay method. The result sare summarized as follows: 1) Among 57 patients with post-transfusion hepatitis(PTH), 38(66.7%) were positive for anti-HCV. Four out of 57 patients were also positive for HBsAg, of which three were positive for anti-HCV. 2) In 131 patients with chronic non-A, non-B hepatitis, who had no history of blood transfusions, 60(45.8%) were positive for anti-HCV; of them 42 out of 85(49.4%) patients with chronic hepatitis, 14 out of 34(41.2%) with liver cirrhosis, and four out of 12(33.3%) with fatty liver and alcoholic hepatitis were positive for anti-HCV. 3) In 27 patients with HBsAg negative hepatocellular carcinoma, 13(48.1%) were positive for anti-HCV. 4) In 25 patients with chronic hepatitis B, who were negative for HBeAg but had active liver disease by liver biopsy, two(8%) were positive for anti-HCV. In conclusion, the prevalence of type C hepatitis in Korea was similar to that of other countries. This test is useful in confirming the diagnosis of various chronic viral hepatitis patients in Korea. Meanwhile, studies of larger numbers of patients and blood donors are necessary to estimate the exact prevalence of this type of hepatitis in Korea.